Mr. Garen Sarafian reports

BAUSCH HEALTH TO ANNOUNCE SECOND QUARTER 2026 RESULTS ON JULY 29, 2026

Bausch Health Companies Inc. will release second quarter 2026 financial results after market close on Wednesday, July 29, 2026. Bausch Health will host a live conference call and webcast at 5 p.m. EDT to discuss results and provide a business update. All materials will be made available on the investor relations section of the Bausch Health website prior to the start of the call.

Conference call details

Date:  Wednesday, July 29, 2026

Time:  5 p.m. EDT

Webcast:  available on Bausch Health's website

A replay of the conference call will be available on the Bausch Health investor relations website.

About Bausch Health Companies Inc.

Bausch Health is a global diversified pharmaceutical company enriching lives through the company's relentless drive to deliver better health care outcomes. Bausch Health develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through its controlling interest in Bausch + Lomb. Bausch Health's ambition is to be a globally integrated health care company, trusted and valued by patients, health care providers, employees and investors.